Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
39.42
-0.81 (-2.01%)
At close: Sep 11, 2025, 4:00 PM EDT
38.64
-0.78 (-1.98%)
After-hours: Sep 11, 2025, 7:22 PM EDT
PRAX Market Cap
PRAX has a market cap or net worth of $829.77 million as of September 11, 2025. Its market cap has decreased by -7.19% in one year.
Market Cap
829.77M
Enterprise Value
383.89M
1-Year Change
-7.19%
Ranking
Category
Stock Price
$39.42
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $829.77M, an increase of 18.87%. That is a compound annual growth rate of 3.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 846.82M | -42.84% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | 2.10B | 201.52% |
| Oct 16, 2020 | 698.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |